Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18757091rdf:typepubmed:Citationlld:pubmed
pubmed-article:18757091lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:18757091lifeskim:mentionsumls-concept:C0035648lld:lifeskim
pubmed-article:18757091lifeskim:mentionsumls-concept:C0008976lld:lifeskim
pubmed-article:18757091lifeskim:mentionsumls-concept:C1956346lld:lifeskim
pubmed-article:18757091lifeskim:mentionsumls-concept:C0277785lld:lifeskim
pubmed-article:18757091lifeskim:mentionsumls-concept:C0018810lld:lifeskim
pubmed-article:18757091lifeskim:mentionsumls-concept:C0039155lld:lifeskim
pubmed-article:18757091lifeskim:mentionsumls-concept:C2587213lld:lifeskim
pubmed-article:18757091lifeskim:mentionsumls-concept:C0936012lld:lifeskim
pubmed-article:18757091lifeskim:mentionsumls-concept:C0220901lld:lifeskim
pubmed-article:18757091lifeskim:mentionsumls-concept:C1515021lld:lifeskim
pubmed-article:18757091pubmed:issue9641lld:pubmed
pubmed-article:18757091pubmed:dateCreated2008-9-8lld:pubmed
pubmed-article:18757091pubmed:abstractTextThe BEAUTIFUL study assessed the morbidity and mortality benefits of the heart rate-lowering agent ivabradine. The placebo arm of the BEAUTIFUL trial was a large cohort of patients with stable coronary artery disease and left-ventricular dysfunction. We did a subanalysis of this placebo group to test the hypothesis that elevated resting heart rate at baseline is a marker for subsequent cardiovascular death and morbidity.lld:pubmed
pubmed-article:18757091pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18757091pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18757091pubmed:languageenglld:pubmed
pubmed-article:18757091pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18757091pubmed:citationSubsetAIMlld:pubmed
pubmed-article:18757091pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18757091pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18757091pubmed:statusMEDLINElld:pubmed
pubmed-article:18757091pubmed:monthSeplld:pubmed
pubmed-article:18757091pubmed:issn1474-547Xlld:pubmed
pubmed-article:18757091pubmed:authorpubmed-author:GenM CMClld:pubmed
pubmed-article:18757091pubmed:authorpubmed-author:StegP...lld:pubmed
pubmed-article:18757091pubmed:authorpubmed-author:FordIanIlld:pubmed
pubmed-article:18757091pubmed:authorpubmed-author:FerrariRobert...lld:pubmed
pubmed-article:18757091pubmed:authorpubmed-author:TenderaMichal...lld:pubmed
pubmed-article:18757091pubmed:authorpubmed-author:RobertsonMich...lld:pubmed
pubmed-article:18757091pubmed:authorpubmed-author:BEAUTIFUL...lld:pubmed
pubmed-article:18757091pubmed:issnTypeElectroniclld:pubmed
pubmed-article:18757091pubmed:day6lld:pubmed
pubmed-article:18757091pubmed:volume372lld:pubmed
pubmed-article:18757091pubmed:ownerNLMlld:pubmed
pubmed-article:18757091pubmed:authorsCompleteYlld:pubmed
pubmed-article:18757091pubmed:pagination817-21lld:pubmed
pubmed-article:18757091pubmed:dateRevised2009-4-10lld:pubmed
pubmed-article:18757091pubmed:meshHeadingpubmed-meshheading:18757091...lld:pubmed
pubmed-article:18757091pubmed:meshHeadingpubmed-meshheading:18757091...lld:pubmed
pubmed-article:18757091pubmed:meshHeadingpubmed-meshheading:18757091...lld:pubmed
pubmed-article:18757091pubmed:meshHeadingpubmed-meshheading:18757091...lld:pubmed
pubmed-article:18757091pubmed:meshHeadingpubmed-meshheading:18757091...lld:pubmed
pubmed-article:18757091pubmed:meshHeadingpubmed-meshheading:18757091...lld:pubmed
pubmed-article:18757091pubmed:meshHeadingpubmed-meshheading:18757091...lld:pubmed
pubmed-article:18757091pubmed:meshHeadingpubmed-meshheading:18757091...lld:pubmed
pubmed-article:18757091pubmed:meshHeadingpubmed-meshheading:18757091...lld:pubmed
pubmed-article:18757091pubmed:meshHeadingpubmed-meshheading:18757091...lld:pubmed
pubmed-article:18757091pubmed:meshHeadingpubmed-meshheading:18757091...lld:pubmed
pubmed-article:18757091pubmed:meshHeadingpubmed-meshheading:18757091...lld:pubmed
pubmed-article:18757091pubmed:meshHeadingpubmed-meshheading:18757091...lld:pubmed
pubmed-article:18757091pubmed:meshHeadingpubmed-meshheading:18757091...lld:pubmed
pubmed-article:18757091pubmed:year2008lld:pubmed
pubmed-article:18757091pubmed:articleTitleHeart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial.lld:pubmed
pubmed-article:18757091pubmed:affiliationRoyal Brompton Hospital, London, UK.lld:pubmed
pubmed-article:18757091pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18757091pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:18757091pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:18757091pubmed:publicationTypeMulticenter Studylld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18757091lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18757091lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18757091lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18757091lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18757091lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18757091lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18757091lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18757091lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18757091lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18757091lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18757091lld:pubmed